Emmaus Life Sciences to Seek Marketing Approval for First New Sickle Cell Disease Treatment in Nearly 20 Years; Expects to Submit New Drug Application to FDA in SeptemberAugust 22, 2016 Read More
Emmaus Medical Signs Licensing Agreement with Tokyo-Based Regenerative Medicine Company, CellSeedJune 17, 2016 Read More
